IperionX Ltd - ADR [IPX] vs United States [UAMY] Detailed Stock Comparison

IperionX Ltd - ADR

NASDAQ
Loading...

United States

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: IperionX Ltd - ADR wins in 4 metrics, United States wins in 10 metrics, with 0 ties. United States appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricIperionX Ltd - ADRUnited StatesBetter
P/E Ratio (TTM)-45.9932.66IperionX Ltd - ADR
Price-to-Book Ratio190.9724.60United States
Debt-to-Equity Ratio4.262.59United States
PEG Ratio-172.47-1.81IperionX Ltd - ADR
EV/EBITDA-486.35-8,843.59United States
Profit Margin (TTM)0.00%-3.43%IperionX Ltd - ADR
Operating Margin (TTM)0.00%0.19%United States
EBITDA Margin (TTM)N/A0.19%N/A
Return on Equity-49.17%-2.79%United States
Return on Assets (TTM)-30.59%-2.63%United States
Free Cash Flow (TTM)$-26.68M$1.79MUnited States
1-Year Return140.69%919.74%United States
Price-to-Sales Ratio (TTM)N/A38.78N/A
Enterprise Value$18.38B$929.62MIperionX Ltd - ADR
EV/Revenue RatioN/A36.13N/A
Gross Profit Margin (TTM)N/A26.96%N/A
Revenue per Share (TTM)N/A$0N/A
Earnings per Share (Diluted)$-1.20$-0.01United States
Beta (Stock Volatility)0.35-0.10United States
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

IperionX Ltd - ADR vs United States Stock Performance Analysis

Loading Price Chart...

IperionX Ltd - ADR
United States
IperionX Ltd - ADR Stock Overview | United States Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
IperionX Ltd - ADR0.38%8.75%15.41%83.78%250.64%55.90%
United States4.39%24.00%79.81%249.10%232.62%347.98%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
IperionX Ltd - ADR140.69%959.31%806.24%806.24%806.24%806.24%
United States919.74%2,052.78%1,745.24%1,790.24%1,481.63%1,514.58%

News Based Sentiment: IperionX Ltd - ADR vs United States

IperionX Ltd - ADR

News based Sentiment: POSITIVE

October was a demonstrably positive month for IperionX, characterized by a significant increase in share price, analyst upgrades, substantial institutional investment, and continued government funding. These factors collectively suggest growing confidence in the company's prospects and its ability to execute its strategic vision.

View IperionX Ltd - ADR News Sentiment Analysis

United States

News based Sentiment: POSITIVE

The $245 million DLA contract is a game-changer for United States Antimony, securing a significant revenue stream and validating its position in the market. Coupled with expansion plans and positive analyst revisions, this month represents a major turning point for the company and its investors.

View United States News Sentiment Analysis

Performance & Financial Health Analysis: IperionX Ltd - ADR vs United States

MetricIPXUAMY
Market Information
Market Cap i$1.07B$997.64M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i98,23012,307,530
90 Day Avg. Volume i114,5908,391,010
Last Close$55.40$8.09
52 Week Range$12.27 - $56.78$0.49 - $8.59
% from 52W High-2.43%-5.82%
All-Time High$56.78 (Oct 03, 2025)$8.59 (Oct 06, 2025)
% from All-Time High-2.43%-5.82%
Growth Metrics
Quarterly Revenue GrowthN/A1.87%
Quarterly Earnings GrowthN/A-0.11%
Financial Health
Profit Margin (TTM) i0.00%-0.03%
Operating Margin (TTM) i0.00%0.00%
Return on Equity (TTM) i-0.49%-0.03%
Debt to Equity (MRQ) i4.262.59
Cash & Liquidity
Book Value per Share (MRQ)$0.29$0.32
Cash per Share (MRQ)$0.16$0.06
Operating Cash Flow (TTM) i$-21,797,684$-767,649
Levered Free Cash Flow (TTM) i$-27,480,356$-8,479,040
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: IperionX Ltd - ADR vs United States

MetricIPXUAMY
Price Ratios
P/E Ratio (TTM) i-45.9932.66
Forward P/E i-172.4713.84
PEG Ratio i-172.47-1.81
Price to Sales (TTM) iN/A38.78
Price to Book (MRQ) i190.9724.60
Market Capitalization
Market Capitalization i$1.07B$997.64M
Enterprise Value i$18.38B$929.62M
Enterprise Value Metrics
Enterprise to Revenue iN/A36.13
Enterprise to EBITDA i-486.35-8,843.59
Risk & Other Metrics
Beta i0.35-0.10
Book Value per Share (MRQ) i$0.29$0.32

Financial Statements Comparison: IperionX Ltd - ADR vs United States

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)IPXUAMY
Revenue/Sales iN/A$7.00M
Cost of Goods Sold iN/A$4.63M
Gross Profit iN/A$2.37M
Research & Development iN/AN/A
Operating Income (EBIT) iN/A$357,492
EBITDA iN/A$638,962
Pre-Tax Income iN/A$546,524
Income Tax iN/A$0
Net Income (Profit) iN/A$546,524

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)IPXUAMY
Cash & Equivalents i$33.16M$18.75M
Total Current Assets i$41.55M$24.84M
Total Current Liabilities i$3.05M$4.72M
Long-Term Debt i$1.04M$456,625
Total Shareholders Equity i$51.34M$32.59M
Retained Earnings i$-73.88M$-40.60M
Property, Plant & Equipment i$8.60M$410,573

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)IPXUAMY
Operating Cash Flow iN/A$-929,407
Capital Expenditures i$-4.56M$-862,011
Free Cash Flow i$-11.08M$-2.59M
Debt Repayment i$-149,000$-32,632
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricIPXUAMY
Shares Short i101,41117.14M
Short Ratio i1.202.98
Short % of Float i0.00%0.14%
Average Daily Volume (10 Day) i98,23012,307,530
Average Daily Volume (90 Day) i114,5908,391,010
Shares Outstanding i32.94M112.95M
Float Shares i266.36M101.35M
% Held by Insiders i0.00%0.17%
% Held by Institutions i0.12%0.27%

Dividend Analysis & Yield Comparison: IperionX Ltd - ADR vs United States

MetricIPXUAMY
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.40N/A
3-Year Avg Dividend Yield i2.70%N/A
3-Year Total Dividends i$1.20N/A
Ex-Dividend DateMar 01, 2024N/A